By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



111 West Lemon Avenue

Monrovia  California  91016  U.S.A.
Phone: 626-305-5900 Fax: 626-305-0350



Drug Discovery

Company News
Xencor Release: Xenoscope, the Revolutionary Cost-effective Laparoscope, Wins FDA Fast Track Clearance 10/4/2016 8:18:43 AM
Xencor Release: Preliminary Data From The Ongoing Open-Label Xmab5871 Phase 2 Pilot Study In Igg4-Related Disease To Be Presented At American College of Rheumatology 2016 Annual Meeting 10/3/2016 7:30:20 AM
Xencor Grows In San Diego 9/28/2016 7:30:09 AM
Xencor Initiates Phase 1b Trial Of Subcutaneous Formulation Of Xmab7195 9/15/2016 8:40:28 AM
Xencor Doses First Patient In Lead Immuno-Oncology Bispecific Program Xmab14045 For The Treatment Of Acute Myeloid Leukemia And Other CD123-Expressing Hematologic Malignancies 9/12/2016 7:40:15 AM
Xencor To Present At Upcoming Investor Conferences 8/31/2016 11:13:33 AM
Xencor To Present At Upcoming Investor Conferences 8/3/2016 9:59:13 AM
Xencor Reports Second Quarter 2016 Financial Results 8/3/2016 7:17:27 AM
Xencor To Host Second Quarter 2016 Financial Results Webcast And Conference Call On August 2, 2016 7/26/2016 6:58:39 AM
Xencor Provides Updates On Lead Programs And Reviews Bispecific Oncology Partnership; Announces Expansion Of Bispecific Oncology Pipeline At Analyst Day 6/28/2016 8:18:41 AM